MedPointe Pharmaceuticals Announces the Appointment of John J. Howarth to Vice President of Public Affairs and Investor Relations

SOMERSET, N.J., May 30 /PRNewswire/ -- MedPointe Pharmaceuticals today announced the appointment of John J. Howarth to Vice President of Public Affairs and Investor Relations, effective May 29, 2007. Mr. Howarth is a finance and corporate affairs professional with more than 24 years of leadership experience in the healthcare industry, including executive positions at early-stage biotechnology firms, specialty pharmaceutical companies, and large, multi-national pharmaceutical companies.

"We are extremely pleased that Jack has decided to join our leadership team," said Paul Edick, President and CEO of Medpointe Pharmaceuticals. "His wealth of knowledge and successful track record in the industry will complement our highly seasoned management team which has an average tenure of over 20 years in the pharmaceutical industry in both large and small companies."

Mr. Howarth comes to Medpointe with significant experience in finance, investor relations and corporate affairs. Most recently, he was Vice President Investor Relations and Corporate Affairs at Kos Pharmaceuticals prior to their merger with Abbott Laboratories. Previously, he had a career spanning over two decades in the healthcare industry including 17 years at Warner-Lambert Company. Mr. Howarth received his B.S. degree in Accounting from Boston College and an M.B.A. in Finance from Seton Hall University.

MEDPOINTE PHARMACEUTICALS

MedPointe Pharmaceuticals is a privately held, specialty pharmaceutical company located in Somerset, New Jersey. MedPointe specializes in respiratory, allergy, central nervous system, and cough-cold products. The company maintains a manufacturing facility in Decatur, Illinois. For more information on MedPointe, visit www.medpointepharma.com.

MedPointe Pharmaceuticals

CONTACT: John J. Howarth, Vice President Public Affairs & InvestorRelations, MedPointe, Inc., +1-732-564-2297

Back to news